How can biopharmaceutical production be optimized for rare diseases?
Rare diseases are often neglected by the mainstream pharmaceutical industry, as they affect a small number of patients and require specialized and costly treatments. Biopharmaceuticals, which are drugs derived from living organisms or their components, offer a promising alternative for developing therapies for rare diseases, as they can target specific molecular mechanisms and modulate the immune system. However, biopharmaceutical production also faces many challenges, such as low yield, high variability, and complex quality control. In this article, you will learn how biopharmaceutical production can be optimized for rare diseases, using some of the latest technologies and strategies.
-
Abyson Joseph, Ph.D.Experienced Team Lead & Protein Chemist Specializing in Downstream Process Development | Vaccines | Biologics |…
-
Manikanta Koppuravuri, M.Pharm.Senior Manager | Regulatory Expert with 14+ Years' Experience | Driving Successful Approvals & Market Access for…
-
Avishek BasuLinkedIn Top Voice | Global Project Manager (Pharma)